Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Use of hormone replacement therapy among Danish nurses in 1993.

Hundrup YA, Obel EB, Rasmussen NK, Philip J.

Acta Obstet Gynecol Scand. 2000 Mar;79(3):194-201.

PMID:
10716300
2.

Hormone replacement therapy in Norwegian women, 1996-1997.

Bakken K, Eggen AE, Lund E.

Maturitas. 2001 Nov 30;40(2):131-41.

PMID:
11716991
3.
4.

Use of hormone replacement therapy among Danish nurses at increased risk of osteoporosis.

Hundrup YA, Thoning H, Rasmussen NK, Obel EB, Philip J.

Int J Behav Med. 2003;10(3):269-83.

PMID:
14525721
7.

Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.

Li C, Samsioe G, Lidfelt J, Nerbrand C, Agardh CD; Women's Health in Lund Area (WHILA) Study..

Menopause. 2000 Jul-Aug;7(4):273-81.

PMID:
10914621
8.

[Menopause, hormone therapy and self-rated health. A cross-sectional study in Roskilde county in 1998].

Søndergaard KM, Hindsberger C, Toft U, Adser L, Damsgaard JJ, Hvas AC.

Ugeskr Laeger. 2005 Aug 22;167(34):3180-4. Danish.

PMID:
16117918
9.
10.

Women's knowledge of and attitudes towards hormone replacement therapy.

Lewin KJ, Sinclair HK, Bond CM.

Fam Pract. 2003 Apr;20(2):112-9.

PMID:
12651782
11.

Lifestyle factors and choice of hormone replacement therapy among Danish nurses.

Hundrup YA, Thoning H, Obel EB, Rasmussen NK, Philip J.

Scand J Public Health. 2002;30(1):47-53.

PMID:
11928833
12.

Postmenopausal hormone therapy and risk of cognitive decline in community-dwelling aging women.

Kang JH, Weuve J, Grodstein F.

Neurology. 2004 Jul 13;63(1):101-7.

PMID:
15249618
13.

Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.

Ness J, Aronow WS, Newkirk E, McDanel D.

J Gerontol A Biol Sci Med Sci. 2005 Apr;60(4):460-2.

PMID:
15933383
14.

The use of hormone replacement therapy; results of a community survey.

Griffiths F, Jones K.

Fam Pract. 1995 Jun;12(2):163-5.

PMID:
7589939
15.
16.

[Hormone replacement therapy in the peri-menopausal and post menopausal period: more than half of the women were treated for more than one year].

Tobi H, van den Berg PB, Brouwers JR, de Jong-van den Berg LT.

Ned Tijdschr Geneeskd. 2003 Sep 20;147(38):1853-5. Dutch.

PMID:
14533498
17.

The role of treatment intentions and concerns about side effects in women's decision to discontinue postmenopausal hormone therapy.

Reynolds RF, Obermeyer CM, Walker AM, Guilbert D.

Maturitas. 2002 Nov 20;43(3):183-94.

PMID:
12443835
18.
19.

Socioeconomic status and use of postmenopausal hormone replacement therapy among Danish women.

Olesen AV, Johnsen SP, Mortensen JT, Bøggild H, Olsen J, Sørensen HT.

Acta Obstet Gynecol Scand. 2005 Jul;84(7):639-44.

PMID:
15954872
20.

Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study .

Sandini L, Pentti K, Tuppurainen M, Kröger H, Honkanen R.

Menopause. 2008 Mar-Apr;15(2):282-9.

PMID:
17998884
Items per page

Supplemental Content

Support Center